Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
New Fact Sheet On Breast Cancer And Molecular Imaging Released By SNM
http://www.medicalnewstoday.com/articles/124213.php
Coinciding with the observance of Nuclear Medicine Week (October 5 to 11) and National Breast Cancer Awareness Month (October), SNM has released a new fact sheet highlighting recent developments in molecular imaging technologies that are dramatically improving the ways in which breast cancer is diagnosed and treated.
To Escape Death By Hormonal Therapy Breast Cancer Cells Recycle
http://www.medicalnewstoday.com/articles/124174.php
Many breast cancer cells facing potentially lethal antiestrogen therapy recycle to survive, researchers say.About 70 percent of breast cancer cells have receptors for the hormone estrogen, which acts as a nutrient and stimulates their growth.
ORLive Presents: IntraBeam(R): Intraoperative Radiation Treatment In Early Stage Breast Cancer
http://www.medicalnewstoday.com/articles/124157.php
Join the live lumpectomy surgery to remove early stage breast cancer and prepare the surgical site for IntraBeam(R), intraoperative radiation therapy that occurs right in the operating room.
Breast Cancer Surgery That Reduces Risk And Improves Cosmetic Appearance - New Research
http://www.medicalnewstoday.com/articles/124117.php
A novel endoscopic-assisted technique for skin-sparing mastectomy with immediate breast reconstruction can successfully treat early breast cancer patients while offering favorable aesthetic results.
Disturbing Trend In Treating Recurrent Breast Cancer Discovered By UC Davis Researchers
http://www.medicalnewstoday.com/articles/124108.php
A majority of women with breast cancer today are candidates for lumpectomy, allowing for conservation of most of their breast tissue. Results of a UC Davis study, however, show that a number of women whose cancer recurs in the same breast are treated with a second lumpectomy rather than a mastectomy, defying current treatment recommendations and cutting the number of years those women survive in half.
Apthera Announces Optimal Dose And Schedule Of NeuVax For Phase III Clinical Trial In Breast Cancer
http://www.medicalnewstoday.com/articles/124052.php
Apthera, Inc. announced the optimized dose and schedule for its lead drug, NeuVax, in treating early-stage breast cancer patients to be used in Phase III clinical trials. Dr. George Peoples, Deputy Director, United States Military Cancer Center, co-authored a publication that appears on the cover of the October 1, 2008, issue of <i>Cancer </i>(Vol.
Mammogram Reading Assisted By Computer Is Effective
http://www.medicalnewstoday.com/articles/124038.php
UK researchers found that the rate of detection of breast cancer by two experts reading a mammogram was the same as one expert using computer aided detection, but there was a slightly but significantly higher recall rate in the computer assisted method.
Access Pharmaceuticals Presents New Data On The Company's Angiolix(R) Therapeutic Monoclonal Antibody
http://www.medicalnewstoday.com/articles/124020.php
Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) presented data this week from preclinical studies on Angiolix showing that by blocking lactadherin, Angiolix has both an anti-angiogenic effect as well as a direct anti-proliferative effect on tumors themselves.
----------------------------------------------
** CANCER / ONCOLOGY News **
Health Services Research Finds Specialty Hospitals Not More Cost-Efficient Than Full-Service Hospitals
http://www.medicalnewstoday.com/articles/124173.php
One of the most notable recent developments in the U.S. hospital industry is the rapid rise of small hospitals specializing in cardiac, orthopedic, or surgical services which have tripled in number over the past 15 years.
Developing GA101, A Humanized Anti-CD20 Monoclonal Antibody With Hematological Malignancies Potential Treatment - Genentech, GlycArt And Roche Collabo
http://www.medicalnewstoday.com/articles/124166.php
Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint development and commercialization of GlycArt's GA101 molecule.
Cancer Treatment Could Be Transformed By Nanodiamond Drug Device
http://www.medicalnewstoday.com/articles/124145.php
A Northwestern University research team has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically removed.
Idera Pharmaceuticals Announces Preliminary Data From Phase 2a Clinical Study Of IMO-2055 Monotherapy In Renal Cell Carcinoma
http://www.medicalnewstoday.com/articles/124050.php
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in patients with metastatic or recurrent clear cell renal carcinoma (RCC).
Developing An Analytic Tool To Assist In Accurately Identifying Leukemia Stem Cells
http://www.medicalnewstoday.com/articles/124046.php
As part of a comprehensive R&D effort to develop an analytic tool to assist in accurately identifying leukemia stem cells, Oerlikon Leybold Vacuum is supporting the StemSpec R&D project at the University of Toronto with a TURBOVAC SL turbomolecular vacuum pump and a fore vacuum pump, and advising researchers about the use of the pumps.
Promising New Anti-Tumor Vaccine Effectively Delivered In Mice
http://www.medicalnewstoday.com/articles/124037.php
Research published in the journal <i>CancerImmunology, Immunotherapy</i> reports that a new anti-tumorvaccine for neuroblastoma and melanoma is significantly impacting tumorgrowth in mice. The vaccine represents a more personal approach totreatment since it uses the tumor's own protein to induce an immunesystem response.
Epstein-Barr Protein Contributes To Cancer
http://www.medicalnewstoday.com/articles/123844.php
A protein in the Epstein-Barr virus (EBV) interferes with cellularprocesses that would normally prevent the preservation of damaged DNA,thereby promoting cancer development, according to an article releasedon October 2, 2008 in the open-access journal <i>PLoSPathogens</i>.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Women Against Cervical Cancer
http://www.medicalnewstoday.com/articles/124144.php
The launch of the Women Against Cervical Cancer (WACC) Network, a new international network of voluntary organisations, institutions, NGOs and individuals committed to the fight against cervical cancer.
CDC Officials Did Not Know HPV Vaccination Recommendation For U.S. Women Also Would Affect Prospective Immigrants
http://www.medicalnewstoday.com/articles/124081.php
Some of the <a href="http://www.cdc.gov/" target="_new">CDC</a> officials who supported a recommendation for young women in the U.S. to receive the human papillomavirus vaccine said they did not intend for it to lead to an immigration policy requiring young immigrant women to receive the vaccine, the <a href="http://wsj.
----------------------------------------------
** COLORECTAL CANCER News **
Vectibix(R) Now Available For The Treatment Of Advanced Colorectal Cancer In Belgium
http://www.medicalnewstoday.com/articles/124167.php
Amgen Belgium announces the availability of Vectibix® (panitumumab), the first fully human anti-EGFR monoclonal antibody indicated as monotherapy for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC) with non-mutated (wild-type) <i>KRAS</i>gene after failure of fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy protocols.
Colonoscopy Associated With Reduced Colorectal Cancer Incidence
http://www.medicalnewstoday.com/articles/124153.php
<b>Incidence reduction in the proximal colon differs in magnitude and timing</b>Patients who undergo a complete negative colonoscopy have a reduced incidence of colorectal cancer, confirms a study published in Clinical Gastroenterology and Hepatology.
----------------------------------------------
** LUNG CANCER News **
Merck KGaA: Survival In 1st-Line Non-Small Cell Lung Cancer (NSCLC) Significantly Prolonged By Erbitux(R)
http://www.medicalnewstoday.com/articles/124131.php
Data presented today at the 1st International Thoracic Oncology Congress Dresden (ITOCD) demonstrate that the addition of Erbitux® (cetuximab) to standard platinum-based chemotherapy in the 1st-line treatment of advanced NSCLC resulted in a significantly longer overall survival.
Johns Hopkins University Researchers To Clinically Assess Rosetta Genomics' MiRview(TM) Squamous Assay
http://www.medicalnewstoday.com/articles/124015.php
Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical assessment study with the Johns Hopkins University School of Medicine.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Developing GA101, A Humanized Anti-CD20 Monoclonal Antibody With Hematological Malignancies Potential Treatment - Genentech, GlycArt And Roche Collabo
http://www.medicalnewstoday.com/articles/124166.php
Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint development and commercialization of GlycArt's GA101 molecule.
Developing An Analytic Tool To Assist In Accurately Identifying Leukemia Stem Cells
http://www.medicalnewstoday.com/articles/124046.php
As part of a comprehensive R&D effort to develop an analytic tool to assist in accurately identifying leukemia stem cells, Oerlikon Leybold Vacuum is supporting the StemSpec R&D project at the University of Toronto with a TURBOVAC SL turbomolecular vacuum pump and a fore vacuum pump, and advising researchers about the use of the pumps.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
New Catheter-less Technique May Ease The Pain And Discomfort Of Prostate Cancer Recovery
http://www.medicalnewstoday.com/articles/124056.php
To ease the pain of recovery following prostate cancer surgery, physician-scientists have developed an innovative and patient-friendly approach that eliminates the use of a penile urinary catheter.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment